About DexCare
DexCare is a private company based in Seattle, Washington. It has reported $67,189,227 raised in two offerings on Form D since March 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 26, 2023 | Jun 27, 2023 | $47,189,230of $60.0M target | 10 | $4.7M | EquityRule 506(b) | Form D ↗ |
| Mar 3, 2021 | Mar 10, 2021 | $19,999,997fully sold | 11 | $1.8M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $67,189,227 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on DexCare's Form D filed Jun 27, 2023.
DK
David Kereiakes
Director
Lynne O'Keefe
Founder and Managing Partner, Define Ventures, director
DS
Derek Streat
Executive officer and director
DC
Earlier filings also listed Toby Cosgrove (director, last listed Sep 2026), Paul Minardi (director, last listed Sep 2026), Matthew Blosl (chief executive officer and director, last listed Sep 2026), Lynne Chou O'Keefe (director, last listed Sep 2026), Branden Fini (director, last listed Sep 2026) and Aaron Martin (director, last listed Mar 2021).
Sources
- SECDexCare, Inc. filing history
- CompanyDexCare privacy policy
- CompanyDexCare company page
- CompanyDexCare contact page